Neuralta Brain Power by Alta Care Laboratoires is an innovative liquid capsule supplement designed to support and strengthen the central nervous system, which is crucial for cognitive ...

NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central ...

In a case report published in the New England Journal of Medicine, doctors explain how they figured out the source of her ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Introduction: Early diagnosis and treatment of central nervous system (CNS) tuberculosis (TB) are very important because of its high morbidity and mortality characteristics. However, the clinical ...

A man who accompanied his wife to Dignitas on one final poignant 'holiday' has spoken up about MP Kim Leadbetter's decision to introduce a multi-disciplinary panel of experts rather than a High Court ...

Patients with ERBB2-positive breast cancer and CNS-only metastasis are at a high risk for CNS-related death but have longer overall survival than those with concomitant extracranial metastases.

Axsome's CEO, Herriot Tabuteau, MD, expressed pride in the company's commitment to improving patient outcomes and emphasized the value of the innovation behind AUVELITY. With the settlement, Axsome ...

Wake up besties, there's a new trending phrase on TikTok: "Nervous system can't tell the difference between..." For the ...

Henry Gosebruch, Neumora’s CEO since 2023, will depart. Elsewhere, Biogen dropped two antisense drugs in a pipeline cull and Voyager hit a setback for its ALS gene therapy.